1,175
Views
8
CrossRef citations to date
0
Altmetric
Letter

Leptomeningeal melanomatosis: Stabilization of disease due to radiation, temozolomide and intrathecal liposomal cytarabine

, , , , , , , & show all
Pages 1260-1262 | Received 27 Apr 2011, Accepted 02 May 2011, Published online: 08 Jul 2011

Figures & data

Figure 1a and c. Axial T1-weighted contrast-enhanced scans (3,0T, TR 550, TE 13) after radiochemotherapy but before treatment with adjuvant TMZ and intrathecal DepoCyte showing widespread subependymal enhancement (a, arrow), parenchymal metastases of the occipital lobe (c, arrow) with perifocal edema (a, arrowhead). b and d. Corresponding images (3,0T, TR 550, TE 13) 12 months later without evidence of leptomeningeal or subependymal lesions (b, arrow) while the cerebral parenchymal metastases (d, arrow) and the perifocal edema (b, arrowhead) increased in size.

Figure 1a and c. Axial T1-weighted contrast-enhanced scans (3,0T, TR 550, TE 13) after radiochemotherapy but before treatment with adjuvant TMZ and intrathecal DepoCyte showing widespread subependymal enhancement (a, arrow), parenchymal metastases of the occipital lobe (c, arrow) with perifocal edema (a, arrowhead). b and d. Corresponding images (3,0T, TR 550, TE 13) 12 months later without evidence of leptomeningeal or subependymal lesions (b, arrow) while the cerebral parenchymal metastases (d, arrow) and the perifocal edema (b, arrowhead) increased in size.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.